Insights

Strategic Collaboration Natera is expanding its oncology and MRD capabilities through partnerships and presentations at major industry events (ESMO 2026) and collaboration with TransCode Therapeutics to accelerate colorectal cancer trials, signaling a sales opportunity for integrated lab services, data analytics, and contract research support.

Advanced MRD Leadership The company highlights ultrasensitive MRD technology (Signatera Genome with Phased and Structural Variants) and ongoing evidence expansion, suggesting a strong upsell path for high-sensitivity diagnostics, data interpretation platforms, and companion assay development.

Global Lab Footprint With ISO 13485, CAP, and CLIA certifications across multiple U.S. laboratories and an ISO 27001-certified subsidiary lab, Natera presents a proven, compliant infrastructure ideal for enterprise customers seeking scalable, regulated genomic testing and data security partnerships.

Financial Momentum Revenue in the multi-billions with substantial funding indicates robust growth capacity and potential for expanding enterprise-level managed services, reagent supply, and long-term service agreements with large healthcare systems and biopharma clients.

Security and Trust Natera emphasizes cybersecurity diligence and credible domains, presenting an opportunity to offer enhanced data governance, secure data exchange, and compliance-focused solutions for clinical trial data management and patient privacy requirements.

Similar companies to Natera

Natera Tech Stack

Natera uses 8 technology products and services including GitHub, Chef Infra, Docker, and more. Explore Natera's tech stack below.

Media & News

Natera's Email Address Formats

Natera uses at least 3 email formats:
Natera Email FormatsExamplePercentage
FLast@natera.comJDoe@natera.com
93%
FiLast@natera.comJoDoe@natera.com
6%
First.Last@natera.comJohn.Doe@natera.com
1%

Frequently Asked Questions

What is Natera's phone number?

Minus sign iconPlus sign icon
You can contact Natera's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Natera's stock symbol?

Minus sign iconPlus sign icon
Natera is a publicly traded company; the company's stock symbol is NTRA.

What is Natera's official website and social media links?

Minus sign iconPlus sign icon
Natera's official website is natera.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Natera generate?

Minus sign iconPlus sign icon
As of October 2026, Natera's annual revenue is estimated to be $1B - $10B.

What is Natera's SIC code and NAICS code?

Minus sign iconPlus sign icon
Natera's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Natera have currently?

Minus sign iconPlus sign icon
As of October 2026, Natera has approximately 6K employees across 6 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer: P. R., Vice President - Us Oncology Commercial: D. B. and Vice President Of Product Management, Oncology: S. F. Explore Natera's employee directory with LeadIQ.

What industry does Natera belong to?

Minus sign iconPlus sign icon
Natera operates in the Biotechnology Research industry.

What technology does Natera use?

Minus sign iconPlus sign icon
Natera's tech stack includes GitHub, Chef Infra, Docker, Amazon Redshift, ADP, UKG, SailPoint and Marketo.

What is Natera's email format?

Minus sign iconPlus sign icon
Natera's email format typically follows the pattern of FLast@natera.com. Find more Natera email formats with LeadIQ.

How much funding has Natera raised to date?

Minus sign iconPlus sign icon
As of October 2026, Natera has raised $1.2B in funding. The last funding round occurred on Sep 07, 2023 for $250M.

When was Natera founded?

Minus sign iconPlus sign icon
Natera was founded in 2004.
Natera logo

Natera

Biotechnology ResearchTexas, United States5001-10000 Employees

Natera is a global biotechnology company focused on cell-free DNA and precision medicine, with core activity in oncology, women's health, and organ health. Its objective is to incorporate personalized genetic testing into standard care to enable earlier, more targeted interventions. Headquartered in Austin, Texas, Natera operates laboratories in Austin and San Carlos that hold ISO 13485 certification and CAP accreditation and are CLIA-certified, while its subsidiary Foresight Diagnostics runs an ISO 27001-certified, CAP-accredited CLIA-lab in Boulder.

The company serves clinicians and health systems seeking molecular diagnostics to support risk assessment and treatment decisions. A notable 2026 development was a strategic collaboration with CytoDyn to study ctDNA dynamics in metastatic colorectal cancer. Its tests are backed by a substantial body of peer-reviewed publications, underscoring its role in the cell-free DNA and precision-medicine field.

Section iconCompany Overview

Phone number
Website
natera.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
NTRA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2004
Employees
5001-10000

Section iconFunding & Financials

  • $1.2B

    Natera has raised a total of $1.2B of funding over 14 rounds. Their latest funding round was raised on Sep 07, 2023 in the amount of $250M as a Post IPO Equity.

  • $1B - $10B

    Natera's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.